EUVIMEDEUVIMED entdecken
Crossref

Visual Investigation of Tumor‐Promoting Fibronectin Potentiated by Obesity in Pancreatic Ductal Adenocarcinoma Using an MR/NIRF Dual‐Modality Dendrimer Nanoprobe

Tingting Xu, Xiaoxuan Xu, Dongfang Liu, Di Chang, Siqi Li, Yeyao Sun, Jinbing Xie, Shenghong Ju iD

Advanced Healthcare Materials · 2023

DOI: 10.1002/adhm.202300787 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Healthcare Materials, 2023. Verfasst von Tingting Xu und 7 weiteren Autor:innen. Beteiligte Einrichtung: Jiangsu Key Laboratory of Molecular and Functional Imaging, Department of Radiology, Zhongda Hospital, Medical School of Southeast University, Nanjin…. Hauptthemen laut MEDLINE: Fibronectins, Dendrimers, Carcinoma, Pancreatic Ductal, Obesity. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 89 Literaturangaben. Gefördert von: National Nature Science Foundation of China, Key Research and Development Program of Jiangsu Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Pancreatic ductal adenocarcinoma (PDAC) is a lethal disease characterized by dense stroma. Obesity is an important metabolic factor that greatly increases PDAC risk and mortality, worsens progression and leads to poor chemotherapeutic outcomes. With omics analysis, magnetic resonance and near‐infrared fluorescence (MR/NIRF) dual‐modality imaging and molecular functional verification, obesity as an important risk factor is proved to modulate the extracellular matrix (ECM) components and enhance Fibronectin (FN) infiltration in the PDAC stroma, that promotes tumor progression and worsens response to chemotherapy by reducing drug delivery. In the study, to visually evaluate FN in vivo and guide PDAC therapy, an FN‐targeted nanoprobe, NP‐CREKA, is synthesized by conjugating gadolinium chelates, NIR797 and fluorescein isothiocyanate to a polyamidoamine dendrimer functionalized with targeting peptides. A dual‐modality strategy combining MR and NIRF imaging is applied, allowing effective visualization of FN in orthotopic PDAC with high spatial resolution, ideal sensitivity and excellent penetrability, especially in obese mice. In conclusion, the findings provide new insights into the potential of FN as an ideal target for therapeutic evaluation and improving treatment efficacy in PDAC, hopefully improving the specific management of PDAC in lean and obese hosts.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

FibronectinsDendrimersCarcinoma, Pancreatic DuctalObesityPancreatic NeoplasmsMagnetic Resonance ImagingNanoparticlesAnimalsMiceHumansCell Line, Tumor

Stichwörter der Autor:innen

MRdrug deliveryfibronectinnanoprobespancreatic ductal adenocarcinoma

Substanzen

FibronectinsDendrimers

Autor:innen und Institutionen

  • Jiangsu Key Laboratory of Molecular and Functional Imaging, Department of Radiology, Zhongda Hospital, Medical School of Southeast University, Nanjing, 210009, China.

ORCID-Profile: Shenghong Ju

Förderung

  • National Nature Science Foundation of China
  • Key Research and Development Program of Jiangsu Province

Zitieren

APA

Xu, T., Xu, X., Liu, D., Chang, D., Li, S., Sun, Y., Xie, J., & Ju, S. (2023). Visual Investigation of Tumor‐Promoting Fibronectin Potentiated by Obesity in Pancreatic Ductal Adenocarcinoma Using an MR/NIRF Dual‐Modality Dendrimer Nanoprobe. Advanced Healthcare Materials. https://doi.org/10.1002/adhm.202300787

Vancouver

Xu T, Xu X, Liu D, Chang D, Li S, Sun Y, et al. Visual Investigation of Tumor‐Promoting Fibronectin Potentiated by Obesity in Pancreatic Ductal Adenocarcinoma Using an MR/NIRF Dual‐Modality Dendrimer Nanoprobe. Advanced Healthcare Materials. 2023. doi:10.1002/adhm.202300787

BibTeX
@article{Xu2023,
  author = {Xu, Tingting and Xu, Xiaoxuan and Liu, Dongfang and Chang, Di and Li, Siqi and Sun, Yeyao and Xie, Jinbing and Ju, Shenghong},
  title = {Visual Investigation of Tumor‐Promoting Fibronectin Potentiated by Obesity in Pancreatic Ductal Adenocarcinoma Using an MR/NIRF Dual‐Modality Dendrimer Nanoprobe},
  journal = {Advanced Healthcare Materials},
  year = {2023},
  doi = {10.1002/adhm.202300787}
}
Kostenlos starten →